Mustang Bio
MBIO
37 hedge funds and large institutions have $8.31M invested in Mustang Bio in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
15% more capital invested
Capital invested by funds: $7.25M → $8.31M (+$1.06M)
6% more funds holding
Funds holding: 35 → 37 (+2)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$210K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$105K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$65.1K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$45.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$187K |
| 2 |
Morgan Stanley
New York
|
-$110K |
| 3 |
BlackRock
New York
|
-$108K |
| 4 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
-$56.7K |
| 5 |
SG Americas Securities
New York
|
-$37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $16K | -$5.67K | -2 | -25% |
|
27
Barclays
London,
United Kingdom
| $16K | +$17K | +6 | New |
|
28
Bank of America
Charlotte,
North Carolina
| $15K | -$22.7K | -8 | -57% |
|
29
Citigroup
New York
| $15K | – | – | – |
|
30
JP Morgan Chase
New York
| $13K | -$14.2K | -5 | -50% |
|
31
BNP Paribas Financial Markets
Paris,
France
| $11.7K | +$14.2K | +5 | New |
|
|
GWM
32
Geneos Wealth Management
Englewood,
Colorado
| $11K | +$11.3K | +4 | New |
|
33
Legal & General Group
London,
United Kingdom
| $8K | – | – | – |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $7K | -$8.5K | -3 | -50% |
|
35
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $7K | +$8.5K | +3 | New |
|
|
AIP
36
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | – | – | – |
|
|
MAM
37
Meeder Asset Management
Dublin,
Ohio
| $5K | -$31.2K | -11 | -85% |
|
|
AG
38
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
39
SG Americas Securities
New York
| – | -$37K | -17 | Closed |
|
40
Citadel Advisors
Miami,
Florida
| – | -$34K | -15 | Closed |
|
41
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | – | – |
|
MBIO Hedge Fund Activity: Q1 2019 in Review
37 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q1 2019, worth a combined $8.31M — up 15% from $7.25M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MBIO positions and 2 closed out — a net gain of 2 holders — while 9 added to existing stakes and 11 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $210K. The largest seller was Bridgeway Capital Management, cutting an estimated $187K.
- 37 institutional investors held Mustang Bio (MBIO) as of Q1 2019, up from 35 in Q4 2018.
- Funds reported $8.31M of Mustang Bio stock for Q1 2019, up 15% quarter-over-quarter.
- 4 funds opened new Mustang Bio positions in Q1 2019 and 2 closed out, a net change of +2 holders.
- The largest Mustang Bio buyer in Q1 2019 was Renaissance Technologies, an estimated $210K added.
- The largest Mustang Bio seller in Q1 2019 was Bridgeway Capital Management, an estimated $187K sold.
Based on aggregated 13F filings for Q1 2019.